Results 21 to 30 of about 12,483,860 (378)

Implications of Antigen Selection on T Cell-Based Immunotherapy

open access: yesPharmaceuticals, 2021
Many immunotherapies rely on CD8+ effector T cells to recognize and kill cognate tumor cells. These T cell-based immunotherapies include adoptive cell therapy, such as CAR T cells or transgenic TCR T cells, and anti-cancer vaccines which expand ...
Faye A. Camp, Jill E. Slansky
doaj   +1 more source

CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information Exploration

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Cancer vaccines have gradually attracted attention for their tremendous preclinical and clinical performance. With the development of next-generation sequencing technologies and related algorithms, pipelines based on sequencing and machine learning ...
Jijun Yu   +15 more
doaj   +1 more source

Synthetic tumor-associated glycopeptide antigens. [PDF]

open access: yesEnvironmental Health Perspectives, 1990
Glycopeptides with TN antigen (GalNAc)Ser/Thr and T-antigen structures (beta Gall-3GalNAc)Ser/Thr, described as tumor-associated antigens, were synthesized and coupled to bovine serum albumin. Alternatively, synthetic methods for the construction of beta-anomeric analogues of the TN and T-antigen glycopeptides were developed, aiming at antigenic ...
KUNZ, H.   +7 more
openaire   +4 more sources

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer

open access: yesFrontiers in Oncology, 2023
IntroductionThe diagnostic value of 7 tumor-associated autoantibodies (AABs) including p53, PGP9.5, SOX2, GAGE7, GBU4-5, MEGEA1, and CAGE for the detection of lung cancer has shown inconsistency in several studies.
Yu Xu   +12 more
doaj   +1 more source

Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

open access: yesOncoImmunology, 2022
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide due to high recurrence rates after curative treatment and being frequently diagnosed at an advanced stage.
Lisanne Noordam   +12 more
doaj   +1 more source

Tumor antigens and vaccines in colorectal cancer

open access: yesMedicine in Drug Discovery, 2022
Colorectal cancer (CRC) is a common cancer in the world and also has a high death rate. It is reported that vaccination is a great strategy for CRC. CRC vaccines are based on CRC tumor antigens, including tumor-associated antigens like CEA, MUC-1, CTAs ...
Zhongen Wu, Mengxuan Yang, Yiou Cao
doaj   +1 more source

Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy

open access: yesJournal of Cancer Research and Clinical Oncology, 2020
Bispecific antibodies (BsAbs) have emerged as a leading drug class for cancer therapy and are becoming increasingly of interest for therapeutic applications.
Shu-Yu Huang   +3 more
semanticscholar   +1 more source

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

open access: yesFrontiers in Immunology, 2020
Over the last decades, T-cell immunotherapy has revealed itself as a powerful, and often curative, strategy to treat blood cancers. In hematopoietic cell transplantation, most of the so-called graft-vs.-leukemia (GVL) effect hinges on the recognition of ...
Valérie Janelle   +6 more
doaj   +1 more source

Identification of tumor-associated antigens with multi-cancer therapeutic potential. [PDF]

open access: goldFront Immunol
Wickland DP   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy